Cytek Biosciences (CTKB) Shareholder's Equity (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytek Biosciences | - | - | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.12% |
| Dec 31, 2025 | -9.73% |
| Sep 30, 2025 | 0.27% |
| Jun 30, 2025 | -0.54% |
| Mar 31, 2025 | -4.07% |
| Dec 31, 2024 | 2.67% |
| Sep 30, 2024 | -0.94% |
| Jun 30, 2024 | -0.89% |
| Mar 31, 2024 | -0.11% |
| Dec 31, 2023 | -5.41% |
| Sep 30, 2023 | -2.04% |
| Jun 30, 2023 | 0.17% |
| Mar 31, 2023 | -0.49% |
| Dec 31, 2022 | 2.17% |
| Sep 30, 2022 | 1.31% |
| Jun 30, 2022 | 0.90% |
| Mar 31, 2022 | 0.51% |
| Dec 31, 2021 | 0.54% |
| Sep 30, 2021 | 3,770.41% |
| Jun 30, 2021 | -1,098.64% |
| Mar 31, 2021 | 106.86% |
| Dec 31, 2020 | 41.48% |
| Sep 30, 2020 | 20.14% |